Astria Therapeutics, Inc.
ATXS
$4.04
$0.061.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 328.13M | 344.28M | 354.70M | 369.91M | 246.53M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.51M | 7.58M | 3.02M | 4.45M | 4.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 163.00K | 163.00K | -- |
| Total Current Assets | 334.64M | 351.86M | 357.89M | 374.52M | 250.94M |
|
|
|||||
| Total Current Assets | 334.64M | 351.86M | 357.89M | 374.52M | 250.94M |
| Net Property, Plant & Equipment | 5.11M | 5.39M | 5.72M | 210.00K | 363.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.61M | 4.39M | 4.39M | 4.08M | 3.36M |
| Total Assets | 342.36M | 361.64M | 367.99M | 378.81M | 254.67M |
|
|
|||||
| Total Accounts Payable | 4.32M | 1.28M | 2.34M | 862.00K | 1.51M |
| Total Accrued Expenses | 13.43M | 13.07M | 12.78M | 10.04M | 9.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38M | 1.38M | 1.25M | 168.00K | 329.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.13M | 15.72M | 16.37M | 11.07M | 11.55M |
|
|
|||||
| Total Current Liabilities | 19.13M | 15.72M | 16.37M | 11.07M | 11.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.97M | 4.26M | 4.54M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.10M | 19.99M | 20.91M | 11.07M | 11.55M |
|
|
|||||
| Common Stock & APIC | 898.57M | 895.17M | 876.43M | 872.89M | 728.33M |
| Retained Earnings | -674.79M | -649.17M | -624.63M | -600.46M | -580.53M |
| Treasury Stock & Other | 163.00K | 331.00K | -45.00K | -14.00K | -- |
| Total Common Equity | 223.94M | 246.33M | 251.75M | 272.41M | 147.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
|
|
|||||
| Total Common Equity | 223.94M | 246.33M | 251.75M | 272.41M | 147.79M |
| Total Preferred Equity | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 319.26M | 341.65M | 347.08M | 367.74M | 243.12M |
|
|
|||||